1 Subjects: “...Biological Products / therapeutic use...”

2 Subjects: “...Biological Products / therapeutic use...”

3 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

4 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

5 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

6 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

7

8

9 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

10 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

11 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

12 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

13 “... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...”

14 “..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...”

15 “..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...”

16 “... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...”

17 “... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....”

18 “... microvascular leakage, and lessen mucus production. Although benefit of its use in CF has not been proven, ICS...”

19 “... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....”

20 “... microvascular leakage, and lessen mucus production. Although benefit of its use in CF has not been proven, ICS...”